Catherine Ortemann‐Renon
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Cardiac electrophysiology and arrhythmias, Biomedical Research and Pathophysiology, Sphingolipid Metabolism and Signaling, Cannabis and Cannabinoid Research
Most-Cited Works
- → Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase(2015)177 cited
- → The IQ‐CSRC Prospective Clinical Phase 1 Study: “Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study?”(2013)99 cited
- → One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency(2021)87 cited
- → Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers(2012)81 cited
- → Clinical assessment of drug-induced QT prolongation in association with heart rate changes(2005)68 cited
- → Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects(2020)66 cited
- → Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results(2022)60 cited
- → Around‐the‐clock oral THC effects on sleep in male chronic daily cannabis smokers(2013)49 cited
- → The Challenges of Predicting Drug-Induced QTc Prolongation in Humans(2022)43 cited
- → Quantitative Systems Pharmacology Modeling of Acid Sphingomyelinase Deficiency and the Enzyme Replacement Therapy Olipudase Alfa Is an Innovative Tool for Linking Pathophysiology and Pharmacology(2018)34 cited